-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Lb Pharmaceuticals Inc quarterly Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q3 2024 to Q3 2025.
- Lb Pharmaceuticals Inc Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2025 was 5.81M shares, a 1517% increase year-over-year.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)